Detalhe da pesquisa
1.
Quantitative chemical proteomics identifies novel targets of the anti-cancer multi-kinase inhibitor E-3810.
Mol Cell Proteomics
; 13(6): 1495-509, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24696502
2.
The DNA demethylating agent decitabine activates the TRAIL pathway and induces apoptosis in acute myeloid leukemia.
Biochim Biophys Acta
; 1832(1): 114-20, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23046813
3.
Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
Blood
; 120(15): 3058-68, 2012 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-22923494
4.
Endogenous PP2A inhibitor CIP2A degradation by chaperone-mediated autophagy contributes to the antitumor effect of mitochondrial complex I inhibition.
Cell Rep
; 42(6): 112616, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289585
5.
Cabozantinib in neuroendocrine tumors: tackling drug activity and resistance mechanisms.
Endocr Relat Cancer
; 30(12)2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855330
6.
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronaviruses.
Sci Signal
; 16(816): eade0326, 2023 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113337
7.
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
Eur J Med Chem
; 237: 114410, 2022 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35525212
8.
Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2.
J Am Chem Soc
; 132(19): 6827-33, 2010 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-20415477
9.
NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation.
Dev Cell
; 16(3): 466-81, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19289091